Head-to-head · WeighScore
Kin Meds vs Lavender Sky Health
The verdict
Kin Meds takes it — 72.9/100 to 68.4/100.
Kin Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options including Wegovy injection and…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Kin Meds | Lavender Sky Health |
|---|---|---|
| WeighScore | 72.9/100 | 68.4/100 |
| Grade | C | C |
| Scorecard rank | #75 | #152 |
| Semaglutide | $149/mo (brand Wegovy) | $139/mo (starting dose, month to month, Southend Pharmacy, compounded) |
| Tirzepatide | $149/mo (brand Zepbound) | $149/mo (starting dose, month to month, ReviveRx, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #75 · C
Strengths
- Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
- Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
- LegitScript verified
- Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
- Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health
Where it loses points
- Legal entity name and state of incorporation not publicly disclosed
- The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
- Per-state availability not listed
- $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
- Lab work and dose-titration support not clearly described
Graded #152 · C
Strengths
- The treatment-plan pricing page publishes every pharmacy's full ladder rather than one headline figure, so the cheaper prepaid tiers are visible alongside the monthly ones
- A genuine month-to-month starter plan exists with no prepay, and the cheapest of them is what is filed above — Southend for semaglutide, ReviveRx for tirzepatide
- Compounded plans include the price of the medication, and shipping and supplies are stated as included
- Both semaglutide and tirzepatide are offered, across roughly ten named compounding pharmacies
Where it loses points
- This is a marketplace, not one price: every figure belongs to a named pharmacy on a named plan, and the pharmacy and plan have to travel with the number for it to mean anything
- Most of the ladder is prepaid — Tier plans need 8-10 weeks up front and Extended plans 3-4 months — and only a handful of the pharmacies publish a month-to-month starter plan at all
- Brand-name plans add a separate $25 monthly treatment-plan fee and explicitly do not include the price of the medication; only the compounded plans include it
- No price appears on the homepage, and the pricing page is the only place the ladders are published
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.